Role of therapeutic drug monitoring (TDM) in pediatric anti-convulsant drug dosing

Cox, 1989, Providing effective therapeutic drug monitoring services, Ther Drug Monit, 11, 310, 10.1097/00007691-198905000-00014 Walson, 1989, Neonatal therapeutic drug monitoring — its clinical relevance, Ther Drug Monit, 11, 425, 10.1097/00007691-198907000-00010 Walson, 1980, Once daily doses of phenobarbital in children, J Pediatr, 97, 303, 10.1016/S0022-3476(80)80502-6 Suzuki, 1991, Phenobarbital doses necessary to achieve ‘therapeutic’ concentrations in children, Dev Pharmacol Ther, 17, 79, 10.1159/000457502 O'Dougherty, 1987, Carbamazepine plasma concentration: relationship to cognitive impairment, Arch Neurol, 44, 863, 10.1001/archneur.1987.00520200065021 Suzuki, 1991, Carbamazepine age-dose-ratio relationship in children, Ther Drug Monit, 13, 201, 10.1097/00007691-199105000-00003 Suzuki, 1991, Valproic acid dosages necessary tomaintain therapeutic concentrations in children, Ther Drug Monit, 13, 314, 10.1097/00007691-199107000-00006 Curless, 1976, Phenytoin kinetics in children, Neurology, 26, 715, 10.1212/WNL.26.8.715 Jung, 1980, Effect of dose on phenytoin absorption, Clin Pharmacol Ther, 28, 479, 10.1038/clpt.1980.191 Banner, 1982, Effects of single large doses of phenytoin on glucose homeostasis — a preliminary report, J Clin Pharmacol, 22, 79, 10.1002/j.1552-4604.1982.tb02652.x Edge, 1991, Clonazepam and 7-aminoclonazepam in human plasma, Ther Drug Monit, 13, 363, 10.1097/00007691-199107000-00014